Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BS01 in Geographic Atrophy Secondary to Dry AMD
NCT07158775Phase 2Recruiting
- Sponsor
- Bionic Sight
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Gene Editing, Gene Silencing, AAV Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of BS01 in dry age-related macular degeneration, sponsored by Bionic Sight. Started Jan 2026; status: recruiting.
02
Drugs
BS01
03
Conditions
dry age-related macular degeneration
Beyond the preview
Go deeper on NCT07158775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07158775.